Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment

European Respiratory Review

Volumn 23, Issue 131, 2014, Pages 106-110

  Cottin, Vincent ^a,b   Richeldi, Luca ^c,d  

^a LOUIS PRADEL HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PIRFENIDONE;

COMPUTER ASSISTED TOMOGRAPHY; CRACKLE; DIAGNOSTIC VALUE; DISEASE DURATION; DRUG APPROVAL; EARLY DIAGNOSIS; EARLY INTERVENTION; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTED TOMOGRAPHY; HUMAN; LUNG BIOPSY; NEGLECTED DISEASE; OPTICAL RESOLUTION; RADIATION DOSE; REVIEW; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

EARLY DIAGNOSIS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PATIENT CARE TEAM; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84895446095     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00008613     Document Type: Review

References (17)

1. Cordier JF, Cottin V. Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis. Eur Respir J 2013; 42: 916-923.
2. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' of observations on male British doctors. BMJ 2004; 328: 1519.
3. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006; 3: 329-328.
4. Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172: 1146-1152.
5. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009; 10: 45-61.
6. Garcia CK. Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc 2011; 8: 158-162.
7. Diaz de Leon A. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One 2010; 5: el0680.
8. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
9. Chambers DC, Clarke BE, McGaughran J, et al. Lung fibrosis, premature graying, and macrocytosis. Am J Respir Crit Care Med 2012; 186: e8-e9.
10. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183: 431-440.
11. Palfrey S. Daring to practice low-cost medicine in a high-tech era. N Engl J Med 2011; 364: e21.
12. Lamas DJ, Kawut SM, Bagiella E, et al. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011; 184: 842-847.
13. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
14. National Institute for Health and Care Excellence. Idiopathic pulmonary fibrosis. The diagnosis and management of suspected idiopathic pulmonary fibrosis. 2013. www.nice.org.uk/nicemedia/live/14183/64124/64124.pdf Date last accessed: October 25, 2013.
15. Cottin V, Cordier JF. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis. Eur Respir J 2012; 40: 519-521.
16. Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013; 268: 563-571.
17. Cordier JF, Cottin V, Khouatra C, et al. Screening for lung cancer and idiopathic pulmonary fibrosis: killing two birds with one stone. Radiology 2014 [In press].